Offer - Urjas Oil for just ₹ 1 X
Lignocip 2 % Injection is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Local Anesthesia. Other than this, Lignocip 2 % Injection has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Lignocip 2 % Injection depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Lignocip 2 % Injection also has some side effects, the most common being Skin redness. While these are the most often observed Lignocip 2 % Injection side effects, there are can be others also. These have been listed below. Normally, these side effects of Lignocip 2 % Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Lignocip 2 % Injection's effect during pregnancy is Mild and Mild while nursing. Further, the section on Lignocip 2 % Injection related warnings talks about Lignocip 2 % Injection's effects on the liver, heart and kidney.
Lignocip 2 % Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Lignocip 2 % Injection in conditions like Heart Failure, Liver Disease. Other contraindications of Lignocip 2 % Injection have been discussed in the sections ahead.
Drug reaction of Lignocip 2 % Injection with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Lignocip 2 % Injection is not safe while driving, and is is not addictive in nature.
Lignocip 2 % Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Lignocip 2 % Injection safe for pregnant women?
Pregnant women may get mild side effects from Lignocip.
Is the use of Lignocip 2 % Injection safe during breastfeeding?
Lignocip has been seen to have minimal side effects on breastfeeding women.
What is the effect of Lignocip 2 % Injection on the Kidneys?
Very few cases of side effects of Lignocip on kidney have been reported.
What is the effect of Lignocip 2 % Injection on the Liver?
Side effects of Lignocip rarely affect the liver.
What is the effect of Lignocip 2 % Injection on the Heart?
Lignocip has very mild side effects on the heart.
Lignocip 2 % Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lignocip 2 % Injection unless your doctor advises you to do so -
Is this Lignocip 2 % Injection habit forming or addictive?
Forming a habit of Lignocip 2 % Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Lignocip 2 % Injection. So it is best to avoid driving.
Is it safe?
Lignocip 2 % Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Lignocip 2 % Injection is unable to treat or cure mental disorders.
Interaction between Food and Lignocip 2 % Injection
Some foods when eaten with Lignocip 2 % Injection can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Lignocip 2 % Injection
Information about the interaction of Lignocip 2 % Injection and alcohol is not currently available because this topic has not been researched yet.
Yes, Lignocip may cause an allergic reaction which might manifest as sneezing, wheezing, pruritis (severe itching of the skin), urticaria (localized swollen itchy area), episodes of angioneurotic edema (swelling of the lower layer of skin or mucous membranes and even anaphylactic shock (very severe allergic reaction). If you develop any of these symptoms while using Lignocip, please inform your doctor immediately.
Yes, Lignocip is used topically for producing an anesthetic effect (Prevent pain) on the irritated or inflamed mucous membranes of mouth and pharynx. It is also used for minimizing gagging during X-ray procedure and dental impressions.
No, Lignocip is not a narcotic. It is a local anesthetic agent which is used to cause numbness and block pain. Narcotics are the natural products like opium and its derivatives, heroin, coca leaf, and cannabis, synthetic drugs like pethidine, methadone, codeine, and morphine. These are also prescription drugs and must be taken cautiously as these can cause an addiction.
Lignocip is available as a topical solution, gel, patch, spray, and injection. It is a prescription drug, hence, one must not use it on his/her own. It should be taken under medical supervision only. It should be stored away from the reach of children and pets.
Lignocip is a brand name for lidocaine. It is a prescription drug that belongs to the class of medications called local anesthetic agent. Lignocip is available in different dosage forms such as injection, gel, spray, patch, and solution. It is mainly used to reduce pain and discomfort caused by skin irritation and sunburn. Some form of Lignocip is used to reduce pain and discomfort arises before certain surgery (small) and medical examination or procedure. The injectable form of Lignocip is mainly used for the treatment of ventricular arrhythmias (irregular heartbeat).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775